Immutep Ltd ADR Net Income
| IMMP Stock | USD 2.77 0.13 4.92% |
As of the 17th of February 2026, Immutep retains the Downside Deviation of 3.71, market risk adjusted performance of 0.8652, and Risk Adjusted Performance of 0.1338. Immutep technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immutep Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 803.4196 | Revenue | Earnings Share (0.40) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -55.3 M | -52.5 M | |
| Net Loss | -38.4 M | -40.4 M | |
| Net Loss | -35.9 M | -37.7 M | |
| Net Loss | (0.04) | (0.04) | |
| Net Income Per E B T | 0.90 | 0.78 |
Immutep | Net Income | Build AI portfolio with Immutep Stock |
Evaluating Immutep's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Immutep Ltd ADR's fundamental strength.
Latest Immutep's Net Income Growth Pattern
Below is the plot of the Net Income of Immutep Ltd ADR over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Immutep Ltd ADR financial statement analysis. It represents the amount of money remaining after all of Immutep Ltd ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Immutep's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immutep's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (61.43 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Immutep Net Income Regression Statistics
| Arithmetic Mean | (30,023,170) | |
| Coefficient Of Variation | (64.51) | |
| Mean Deviation | 16,241,934 | |
| Median | (29,902,624) | |
| Standard Deviation | 19,367,716 | |
| Sample Variance | 375.1T | |
| Range | 60.1M | |
| R-Value | (0.68) | |
| Mean Square Error | 216.5T | |
| R-Squared | 0.46 | |
| Significance | 0 | |
| Slope | (2,598,125) | |
| Total Sum of Squares | 6001.7T |
Immutep Net Income History
Other Fundumenentals of Immutep Ltd ADR
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Immutep Net Income component correlations
Immutep Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Immutep is extremely important. It helps to project a fair market value of Immutep Stock properly, considering its historical fundamentals such as Net Income. Since Immutep's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immutep's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immutep's interrelated accounts and indicators.
Click cells to compare fundamentals
Can Biotechnology industry sustain growth momentum? Does Immutep have expansion opportunities? Factors like these will boost the valuation of Immutep. Market participants price Immutep higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Immutep demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth 0.095 | Return On Assets | Return On Equity |
Immutep Ltd ADR's market price often diverges from its book value, the accounting figure shown on Immutep's balance sheet. Smart investors calculate Immutep's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Immutep's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immutep's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immutep is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immutep's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immutep 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immutep's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immutep.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Immutep on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Immutep Ltd ADR or generate 0.0% return on investment in Immutep over 90 days. Immutep is related to or competes with ProQR Therapeutics, Candel Therapeutics, Allogene Therapeutics, Capricor Therapeutics, Editas Medicine, Mereo BioPharma, and Vanda Pharmaceuticals. Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical products More
Immutep Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immutep's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immutep Ltd ADR upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.71 | |||
| Information Ratio | 0.1471 | |||
| Maximum Drawdown | 34.19 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 7.41 |
Immutep Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immutep's standard deviation. In reality, there are many statistical measures that can use Immutep historical prices to predict the future Immutep's volatility.| Risk Adjusted Performance | 0.1338 | |||
| Jensen Alpha | 0.7386 | |||
| Total Risk Alpha | 0.5073 | |||
| Sortino Ratio | 0.1981 | |||
| Treynor Ratio | 0.8552 |
Immutep February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1338 | |||
| Market Risk Adjusted Performance | 0.8652 | |||
| Mean Deviation | 3.48 | |||
| Semi Deviation | 3.1 | |||
| Downside Deviation | 3.71 | |||
| Coefficient Of Variation | 634.03 | |||
| Standard Deviation | 4.99 | |||
| Variance | 24.94 | |||
| Information Ratio | 0.1471 | |||
| Jensen Alpha | 0.7386 | |||
| Total Risk Alpha | 0.5073 | |||
| Sortino Ratio | 0.1981 | |||
| Treynor Ratio | 0.8552 | |||
| Maximum Drawdown | 34.19 | |||
| Value At Risk | (5.43) | |||
| Potential Upside | 7.41 | |||
| Downside Variance | 13.75 | |||
| Semi Variance | 9.64 | |||
| Expected Short fall | (4.11) | |||
| Skewness | 2.0 | |||
| Kurtosis | 9.15 |
Immutep Ltd ADR Backtested Returns
Immutep appears to be unstable, given 3 months investment horizon. Immutep Ltd ADR holds Efficiency (Sharpe) Ratio of 0.18, which attests that the entity had a 0.18 % return per unit of risk over the last 3 months. By evaluating Immutep's technical indicators, you can evaluate if the expected return of 0.91% is justified by implied risk. Please utilize Immutep's Risk Adjusted Performance of 0.1338, downside deviation of 3.71, and Market Risk Adjusted Performance of 0.8652 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Immutep holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 0.91, which attests to possible diversification benefits within a given portfolio. Immutep returns are very sensitive to returns on the market. As the market goes up or down, Immutep is expected to follow. Please check Immutep's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Immutep's current trending patterns will revert.
Auto-correlation | -0.54 |
Good reverse predictability
Immutep Ltd ADR has good reverse predictability. Overlapping area represents the amount of predictability between Immutep time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immutep Ltd ADR price movement. The serial correlation of -0.54 indicates that about 54.0% of current Immutep price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.54 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Immutep Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Immutep Ltd ADR reported net income of (61.43 Million). This is 118.0% lower than that of the Biotechnology sector and 187.71% lower than that of the Health Care industry. The net income for all United States stocks is 110.76% higher than that of the company.
Immutep Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immutep's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immutep could also be used in its relative valuation, which is a method of valuing Immutep by comparing valuation metrics of similar companies.Immutep is currently under evaluation in net income category among its peers.
Immutep Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immutep from analyzing Immutep's financial statements. These drivers represent accounts that assess Immutep's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immutep's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 310.2M | 229.8M | 257.6M | 349.4M | 401.8M | 339.7M | |
| Enterprise Value | 252.9M | 151.6M | 135.4M | 283.6M | 326.2M | 312.8M |
Immutep ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Immutep's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Immutep's managers, analysts, and investors.Environmental | Governance | Social |
Immutep Institutional Holders
Institutional Holdings refers to the ownership stake in Immutep that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Immutep's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immutep's value.| Shares | Fny Investment Advisers, Llc | 2025-06-30 | 18.9 K | Geode Capital Management, Llc | 2025-06-30 | 18.7 K | Xtx Topco Ltd | 2025-06-30 | 15.9 K | Bank Of America Corp | 2025-06-30 | 8.9 K | Hightower Advisors, Llc | 2025-06-30 | 8 K | Tower Research Capital Llc | 2025-06-30 | 4.3 K | Royal Bank Of Canada | 2025-06-30 | 2.1 K | Gamma Investing Llc | 2025-06-30 | 602 | Simplex Trading, Llc | 2025-06-30 | 61.0 | Blackrock Inc | 2025-06-30 | 599.9 K | Meridian Wealth Management, Llc | 2025-06-30 | 372.7 K |
Immutep Fundamentals
| Return On Equity | -0.37 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (20.35) % | ||||
| Current Valuation | 295.18 M | ||||
| Shares Outstanding | 147.19 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 2.24 % | ||||
| Number Of Shares Shorted | 4.64 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 3.81 X | ||||
| Price To Sales | 80.84 X | ||||
| Revenue | 5.04 M | ||||
| Gross Profit | (56.37 M) | ||||
| EBITDA | (62.88 M) | ||||
| Net Income | (61.43 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.63 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (62.05 M) | ||||
| Short Ratio | 23.77 X | ||||
| Earnings Per Share | (0.40) X | ||||
| Target Price | 9.5 | ||||
| Beta | 1.69 | ||||
| Market Capitalization | 407.72 M | ||||
| Total Asset | 156.98 M | ||||
| Retained Earnings | (444.08 M) | ||||
| Working Capital | 180.86 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
| Net Asset | 156.98 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving together with Immutep Stock
Moving against Immutep Stock
| 0.61 | DRMA | Dermata Therapeutics | PairCorr |
| 0.5 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.47 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
| 0.45 | VCEL | Vericel Corp Ord | PairCorr |
| 0.36 | JUMP | Leveljump Healthcare Corp | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.